Blog

Medivation made a name for itself with Xtandi, the prostate cancer med that’s now giving Johnson & Johnson’s ($JNJ) Zytiga a run for its money. Now, it wants to challenge other drugmakers in the PARP inhibitor field, too. The company snapped up BioMarin’s ($BMRN) cancer-fighting PARP inhibitor in a $570 million deal earlier this week,Read more

    Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing entinostat as a combination therapy in multiple cancer indications, said it will partner with Genentech, a member of the Roche Group, in a combination cancer immunotherapy clinical trial. The value of the collaboration was not disclosed.      “This collaboration expands our emerging immuno-oncology program into an importantRead more

    The molecular switches regulating human cell growth do a great job of replacing cells that die during the course of a lifetime. But when they misfire, life-threatening cancers can occur.  Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control theRead more

    We often think of bacteria as a group of rapidly proliferating, free-living cells that don’t typically unite toward a common purpose. However, this couldn’t be further from reality, as microbial existence is much more complex than many may envision. For instance, a number of bacterial species often band together into a collection of cells heldRead more

Cancer is the fiercest disease to human. Scientists always look for the way to fight cancer. We have a good news after a lot of research and testing as Mayo Clinic researchers have discovered an unexpected connection between microRNA processing and cell-to-cell adhesion. This connection, the researchers maintain, not only explains the seemingly incongruous presenceRead more

US regulators have further extended the reach of Ligand/Novartis’ Promacta, allowing its use to treat low blood platelet count in children – aged one year and older – with the rare blood disorder chronic immune thrombocytopenic purpura. Physicians can now prescribe the drug in paediatric patients when they have not achieved an appropriate response usingRead more

    Cytovance® Biologics, biopharmaceutical contract development manufacturing organization, will be acquired by Hepalink USA, the wholly owned U.S. subsidiary of Shenzhen Hepalink Pharmaceutical for $205.68 million cash plus additional contingent payments, Cytovance said.       The deal adds a CDMO to Hepalink’s U.S. portfolio, which includes Scientific Protein Laboratories (SPL), a global supplier of active pharmaceutical ingredientsRead more

    Two important proofreader proteins were discovered by scientists from North Carolina State University and the University of North Carolina at Chapel Hill.  The proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.     During DNA replication, the nucleotides are a correct match mostRead more

    Fat in our body does not always harmful to us.  It does a better job of turning up the metabolic heat, and lessening the risks associated with obesity and diabetes, if it has a favorable balance of energy-storing fat and energy-burning fat. If that favorable balance doesn’t exist naturally, it can be engineered, a newRead more

    Personalized medicine or PM is a medical model that proposes the customization of healthcare – with medical decisions, practices, and/or products being tailored to the individual patient.  One of the main goals of personalized medicine is the ability to quickly and accurately determine the genetic background of a patient and prescribe the appropriate therapy basedRead more